ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity

TY - JOUR

T1 - ACSL4, PUFA, and ferroptosis

T2 - new arsenal in anti-tumor immunity

AU - Gan, Boyi

N1 - Funding Information: The author thanks Guang Lei for generating the figure used in this paper and apologizes to colleagues whose work cannot be cited in this manuscript due to space limitations. Research in the author’s lab has been supported by The University of Texas MD Anderson Cancer Center, National Institutes of Health grants R01CA181196, R01CA244144, and R01CA247992, Cancer Prevention & Research Institute of Texas grant RP220258 (to B.G.), and by Cancer Center Support (Core) Grant P30 CA016672 from the National Cancer Institute (to The University of Texas MD Anderson Cancer Center).

PY - 2022/12

Y1 - 2022/12

UR - http://www.scopus.com/inward/record.url?scp=85128745932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85128745932&partnerID=8YFLogxK

U2 - 10.1038/s41392-022-01004-z

DO - 10.1038/s41392-022-01004-z

M3 - Article

C2 - 35459217

AN - SCOPUS:85128745932

SN - 2095-9907

VL - 7

JO - Signal Transduction and Targeted Therapy

JF - Signal Transduction and Targeted Therapy

IS - 1

M1 - 128

ER -